Severity of chronic Chagas disease is associated with cytokine/antioxidant imbalance in chronically infected individuals

International Journal for Parasitology

Volumn 33, Issue 3, 2003, Pages 293-299

  Pérez Fuentes, Ricardo ^a,b   Guégan, Jean François ^b   Barnabé, Christian ^b   López Colombo, Aurelio ^c   Salgado Rosas, Hilda ^c   Torres Rasgado, Enrique ^c   Briones, Bernardo ^a   Romero Díaz, Mónica ^c   Ramos Jiménez, Judith ^a   Sánchez Guillén, María Del Carmen ^b,c  

^a BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Chagas disease severity; Chronic infectious disease; Cytokine antioxidant imbalance; Glutathione peroxidase; Nitric oxide; Pathogenesis; Superoxide dismutase; Tumour necrosis factor

Indexed keywords

ANTIOXIDANT; CYTOKINE; GLUTATHIONE TRANSFERASE; NITRIC OXIDE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

CHAGAS DISEASE; DISEASE TREATMENT; IMMUNE RESPONSE; PARASITOLOGY; PATHOLOGY;

ADULT; ARTICLE; CHAGAS DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOST SUSCEPTIBILITY; HUMAN; IMMUNE RESPONSE; INFECTION; MALE; NONHUMAN; PATHOGENESIS; TRYPANOSOMA CRUZI;

LATIN AMERICA;

TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0242417521     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7519(02)00283-7     Document Type: Article

References (44)

1. Bachmaier K., Neu N., Pummerer C., Duncan G.S., Mak T.W., Matsuyama T., Penninger J.M. iNOS expression and nitrotyrosine formation in the myocardium in response to inflammation is controlled by the interferon regulatory transcription factor 1. Circulation. 96:1997;585-591.
2. Barbaro G., Fisher S.D., Lipshultz S.E. Pathogenesis of HIV-associated cardiovascular complications. Lancet Infect. Dis. 1:2001;115-124.
3. Binder S., Levitt A.M., Sacks J.J., Hughes J.M. Emerging infectious diseases: public health issues for the 21st century. Science. 284:1999;1311-1313.
4. Braga M.S., Lauria-Pires L., Arganaraz E.R., Nascimento R.J., Teixeira A.R. Persistent infections in chronic Chagas disease patients treated with anti-Trypanosoma cruzi nitroderivatives. Rev. Inst. Med. Trop. Sao Paulo. 42:2000;157-161.
5. Bucio M.I., Cabrera M., Segura E.L., Zenteno E., Salazar-Schettino M. Identification of immunodominant antigens in Mexican strains of Trypanosoma cruzi. Immunol. Invest. 28:1999;257-268.
6. Cardoni R.L., Rottenberg M.E., Segura E.L. Increased production of reactive oxygen species by cells from mice acutely infected with Trypanosoma cruzi. Cell Immunol. 128:1990;11-21.
7. Cervetta L., Basso B., Castro I., Santamarina N., Moretti E. Chagas disease. Serologic response to crude and semipurified Trypanosoma cruzi antigens in different clinical groups of patients. Med. Buenos Aires. 57:1997;161-168.
8. Cetron M.S., Basilio F.P., Moraes A.P., Sousa A.Q., Paes J.N., Kahn S.J., Wener M.H., Van-Voorhis W.C. Humoral and cellular immune response of adults from northeastern Brazil with chronic Trypanosoma cruzi infection: depressed cellular immune response to T. cruzi antigen among Chagas disease patients with symptomatic versus indeterminate infection. Am. J. Trop. Med. Hyg. 49:1993;370-382.
9. Chandra M., Tanowitz H.B., Petkova S.B., Huang H., Weiss L.M., Wittner M., Factor S.M., Shtutin V., Jelicks L.A., Chan J., Shirani J. Significance of inducible nitric oxide synthase in acute myocarditis caused by Trypanosoma cruzi (Tulahuen strain). Int. J. Parasitol. 32:2002;897-905.
10. Crawley M.J. GLIM for Ecologists. 1993;Blackwell Science, Oxford.
11. Farrell A.J., Blake D.R., Palmer R.M., Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann. Rheum. Dis. 51:1992;1219-1222.
12. Fiers W., Beyaert R., Declercq W., Vandenabeele P. More than one way to die: apoptosis, necrosis and reactive oxygen damage. Oncogene. 18:1999;7719-7730.
13. Garcia S.B., Paula J.S., Giovannetti G.S., Zenha F., Ramalho E.M., Zucoloto S., Silva J.S., Cunha F.Q. Nitric oxide is involved in the lesions of the peripheral autonomic neurons observed in the acute phase of experimental Trypanosoma cruzi infection. Exp. Parasitol. 93:1999;191-197.
14. Gazzinelli R.T., Wysocka M., Hieny S., Scharton-Kersten T., Cheever A., Kuhn R., Muller W., Trinchieri G., Sher A. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+T cell and accompanied by overproduction of IL-2, INF-gamma and TNF-alpha. J. Immunol. 157:1996;5177-5184.
15. Grau G.E., Taylor T.E., Molyneux M.E., Wirima J.J., Vassalli P., Hommel M., Lambert P.H. Tumor necrosis factor and disease severity in children with falciparum malaria. N. Engl. J. Med. 320:1989;1586-1591.
16. Habib F.M., Springall D.R., Davies G.J., Oakley C.M., Yacoub M.H., Polak J.M. Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet. 347:1996;1151-1155.
17. Hayes J.D., McLellan L.I. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic. Res. 31:1999;273-300.
18. Hirose K., Longo D.L., Oppenheim J.J., Matsushima K. Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin-1, tumor necrosis factor, selected anticancer drugs, and ionizing radiation. FASEB J. 7:1990;361-368.
19. Huang H., Chan J., Wittner M., Jelicks L.A., Morris S.A., Factor S.M., Weiss L.M., Braunstein V.L., Bacchi C.J., Yarlett N., Chandra M., Shirani J., Tanowitz H.B. Expression of cardiac cytokines and inducible form of nitric oxide synthase (NOS2) in Trypanosoma cruzi-infected mice. J. Mol. Cell Cardiol. 31:1999;75-88.
20. Kalil J., Cunha-Neto E. Autoimmunity in Chagas disease cardiomyopathy: fulfilling the criteria at last? Parasitol. Today. 12:1996;396-399.
21. Laucella S.A., Rottenberg M.E., de Titto E.H. Role of cytokines in resistance and pathology in Trypanosoma cruzi infection. Rev. Argent. Microbiol. 28:1996;99-109.
22. McCullagh P., Nelder J.A. Generalized Linear Models. 2nd Edition: 1989;Chapman and Hall, London.
23. Miller M.J., Sadowska-Krowicka H., Chotinaruemol S., Kakkis J.L., Clark D.A. Amelioration of chronic ileitis by nitric oxide synthase inhibition. J. Pharmacol. Exp. Ther. 264:1993;11-16.
24. Momen H. Taxonomy of Trypanosoma cruzi: a commentary on characterization and nomenclature. Mem. Inst. Oswaldo Cruz. 94:1999;181-184.
25. Moncayo A. Progress towards the elimination of transmission of Chagas disease in Latin America. World Health Stat. Q. 50:1997;195-198.
26. Okomo-Assoumou M.C., Daulouede S., Lemesre J.L., N'Zila-Mouanda A., Vincendeau P. Correlation of high serum levels of tumor necrosis factor-alpha with disease severity in human African trypanosomiasis. Am. J. Trop. Med. Hyg. 53:1995;539-543.
27. Perez-Fuentes R., Sanchez-Guillen M.C., Gonzalez-Alvarez C., Monteon V.M., Reyes P.A., Rosales-Encina J.L. Humoral nitric oxide levels and antibody immune response of symptomatic and indeterminate Chagas disease patients to commercial and autochthonous Trypanosoma cruzi antigen. Am. J. Trop. Med. Hyg. 58:1998;715-720.
28. Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect. Dis. 1:2001;92-100.
29. Romao P.R., Fonseca S.G., Hothersall J.S., Noronha-Dutra A.A., Ferreira S.H., Cunha F.Q. Glutathione protects macrophages and Leishmania major against nitric oxide-mediated cytotoxicity. Parasitology. 118:1999;559-566.
30. Schirmer R.H., Schollhammer T., Eisenbrand G., Krauth-Siegel R.L. Oxidative stress as a defence mechanism against parasitic infections. Free Radic. Res. Commun. 3:1987;3-12.
31. Silva J.S., Vespa G.N., Cardoso M.A., Aliberti J.C., Cunha F.Q. Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infect. Immun. 63:1995;4862-4867.
32. Tarleton R.L., Zhang L. Chagas disease etiology: autoimmunity or parasite persistence? Parasitol. Today. 15:1999;94-99.
33. Tibayrenc M. Integrated genetic epidemiology of infectious diseases: the Chagas model. Mem. Inst. Oswaldo Cruz. 93:1998;577-580.
34. Tibayrenc M., Ward P., Moya A., Ayala F.J. Natural populations of Trypanosoma cruzi, the agent of Chagas disease, have a complex multiclonal structure. Proc. Natl. Acad. Sci. USA. 83:1986;115-119.
35. Truyens C., Torrico F., Angelo-Barrios A., Lucas R., Heremans H., De Baetselier P., Carlier Y. The cachexia associated with Trypanosoma cruzi acute infection in mice is attenuated by anti-TNF-alpha, but not by anti-IL-6 or anti-IFN-gamma antibodies. Parasite Immunol. 17:1995;561-568.
36. Tsujino M., Hirata Y., Imai T., Kanno K., Eguchi S., Ito H., Marumo F. Induction of nitric oxide synthase gene by interleukin-1 beta in cultured rat cardiocytes. Circulation. 90:1994;375-383.
37. Umezawa E.S., Bastos S.F., Camargo S.E., Yamauchi L.M., Santos M.R., Gonzalez A., Zingales B., Levin M.J., Sousa O., Rangel-Aldao R., da Silveira J.F. Evaluation of recombinant antigens for serodiagnosis of Chagas disease in South and Central America. J. Clin. Microbiol. 37:1999;1554-1560.
38. Venables W.N., Ripley B.D. Modern Applied Statistics with S-Plus. 2nd Edition: 1994;Springer, Berlin.
39. Vespa G.N., Cunha F.Q., Silva J.S. Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infect. Immun. 62:1994;5177-5182.
40. Viotti R., Vigliano C., Armenti H., Segura E. Treatment of chronic Chagas disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up. Am. Heart J. 127:1994;151-162.
41. Wong G.H., Goeddel D.V. Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science. 242:1988;941-944.
42. WHO Tech. Rep. Ser. WHO Tech. Rep. Ser. No. 811:1991;WHO, Geneva.
43. Zhang L., Tarleton R.L. Parasite persistence correlates with disease severity and localization in chronic Chagas disease. J. Infect. Dis. 180:1999;480-486.
44. Zhou J., Zhao Q., Yao H. The significance of detecting tumor necrosis factor-alpha and its receptor in serum and pleural effusion in differentiating tuberculosis and malignant pleural effusions. Zhonghua Jie He He Hu Xi Za Zhi. 23:2000;158-160.